Attached files
file | filename |
---|---|
10-Q - Thomas Pharmaceuticals, Ltd. | thomaspharma10q093009.htm |
EX-31.1 - Thomas Pharmaceuticals, Ltd. | ex31-1.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Thomas Pharmaceuticals, Ltd. (the
“Company”), on Form 10-Q for the period ended September 30, 2009, as filed with
the Securities Exchange Commission on the date hereof (the “Report”), the
undersigned, in the capacities and on the dates indicated below, hereby certify,
pursuant to and solely for the purpose of 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the
best of my knowledge:
1.
|
The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
2.
|
The
information contained in the Report fairly presents, in all material
respects the financial condition and results of operations of the
Company.
|
Date: November
16, 2009
By: /s/ Harold Halman
Harold
Halman
President,
Chief Executive Officer and
Chief
Financial Officer